HER-2 PROTEIN OVEREXPRESSION

Clinical trials for HER-2 PROTEIN OVEREXPRESSION explained in plain language.

Never miss a new study

Get alerted when new HER-2 PROTEIN OVEREXPRESSION trials appear

Sign up with your email to follow new studies for HER-2 PROTEIN OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug combo aims to stop deadly esophageal cancer from coming back

Disease control Ongoing

This study tests whether a combination of two drugs (trastuzumab deruxtecan and nivolumab) given for one year after surgery can help prevent cancer from returning in patients with HER2-positive esophageal or gastroesophageal junction cancer. The treatment is for patients who have…

Matched conditions: HER-2 PROTEIN OVEREXPRESSION

Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

HER-2 PROTEIN OVEREXPRESSION

Get alerted when new HER-2 PROTEIN OVEREXPRESSION trials appear

New drug combo aims to stop deadly esophageal cancer from coming back